10468-1-AP
antibody from Proteintech Group
Targeting: CXCL14
BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10468-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10468-1-AP, RRID:AB_2086070
- Product name
- CXCL14 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CXCL14 antibody (Cat. #10468-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Aberrant ROS Mediate Cell Cycle and Motility in Colorectal Cancer Cells Through an Oncogenic CXCL14 Signaling Pathway.
Novel role of CXCL14 in modulating STAR expression in luteinized granulosa cells: implication for progesterone synthesis in PCOS patients.
Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers.
Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.
Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin.
Zeng J, Li M, Xu JY, Xiao H, Yang X, Fan JX, Wu K, Chen S
Frontiers in pharmacology 2021;12:764015
Frontiers in pharmacology 2021;12:764015
Novel role of CXCL14 in modulating STAR expression in luteinized granulosa cells: implication for progesterone synthesis in PCOS patients.
Qi J, Li J, Wang Y, Wang W, Zhu Q, He Y, Lu Y, Wu H, Li X, Zhu Z, Ding Y, Xu R, Sun Y
Translational research : the journal of laboratory and clinical medicine 2021 Apr;230:55-67
Translational research : the journal of laboratory and clinical medicine 2021 Apr;230:55-67
Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
Yu L, Yang X, Xu C, Sun J, Fang Z, Pan H, Han W
International immunopharmacology 2020 Dec;89(Pt B):107077
International immunopharmacology 2020 Dec;89(Pt B):107077
The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers.
Nakayama R, Arikawa K, Bhawal UK
Journal of Cancer 2017;8(15):3014-3027
Journal of Cancer 2017;8(15):3014-3027
Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.
Cho KI, Yoon D, Qiu S, Danziger Z, Grill WM, Wetsel WC, Ferreira PA
Disease models & mechanisms 2017 May 1;10(5):559-579
Disease models & mechanisms 2017 May 1;10(5):559-579
Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
Zeng J, Yang X, Cheng L, Liu R, Lei Y, Dong D, Li F, Lau QC, Deng L, Nice EC, Xie K, Huang C
Journal of translational medicine 2013 Jan 7;11:6
Journal of translational medicine 2013 Jan 7;11:6
Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin.
Yamazaki K, Tanigawa K, Suzuki K, Yamada E, Yamada T, Takano K, Obara T, Sato K
Thyroid : official journal of the American Thyroid Association 2010 Jan;20(1):67-76
Thyroid : official journal of the American Thyroid Association 2010 Jan;20(1):67-76
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human oesophagus cancer using 10468-1-AP(CXCL14 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CXCL14 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CXCL14. This antibody recognizes human,mouse,rat antigen. The CXCL14 antibody has been validated for the following applications: ELISA, IHC analysis.